Vaxinnate Corporation

Cranbury, NJ 08512

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.48MM
First Award Date 05/20/04
Most Recent Award Date 07/01/08

Key Personnel

Last Name Name Awards Contact
Powell Thomas J Powell 2
Price Albert Price 1
Tussey Lynda G Tussey 1

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 07/01/08 - 03/30/10

DESCRIPTION (provided by applicant): We propose to develop a tetravalent dengue (DEN) vaccine using a novel strategy that will ensure broad protection against DEN virus infection. The disease dengue is caused by four mosquito-borne serologically related flaviviruses and development of a DEN vaccine has been particularly challenging because seque...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 07/15/07 - 06/30/08

DESCRIPTION (provided by applicant): We propose to develop a tetravalent dengue (DEN) vaccine using a novel strategy that will ensure broad protection against DEN virus infection. The disease dengue is caused by four mosquito-borne serologically related flaviviruses and development of a DEN vaccine has been particularly challenging because seque...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 05/01/05 - 04/30/07

DESCRIPTION (provided by applicant): The interactions of Toll-like receptors (TLR) with their cognate ligands, Pathogen-Associated Molecular Patterns (PAMPs), trigger the immediate response of the innate immune system and set off a cascade of events that influence the adaptive immune response. PAMP:antigen fusion protein vaccines target the ant...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 05/20/04 - 04/30/05

DESCRIPTION (provided by applicant): The interactions of Toll-like receptors (TLR) with their cognate ligands, Pathogen-Associated Molecular Patterns (PAMPs), trigger the immediate response of the innate immune system and set off a cascade of events that influence the adaptive immune response. PAMP:antigen fusion protein vaccines target the ant...